Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein.
about
Lysostaphin-coated titan-implants preventing localized osteitis by Staphylococcus aureus in a mouse modelFusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent.Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity.In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin.Site-specific N-glycosylation of caprine lysostaphin restricts its bacteriolytic activity toward Staphylococcus aureus.
P2860
Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Inhibition of the activity of ...... lysostaphin immunity protein.
@en
Inhibition of the activity of ...... lysostaphin immunity protein.
@nl
type
label
Inhibition of the activity of ...... lysostaphin immunity protein.
@en
Inhibition of the activity of ...... lysostaphin immunity protein.
@nl
prefLabel
Inhibition of the activity of ...... lysostaphin immunity protein.
@en
Inhibition of the activity of ...... lysostaphin immunity protein.
@nl
P2093
P2860
P356
P1476
Inhibition of the activity of ...... lysostaphin immunity protein.
@en
P2093
Gary L Sloan
Harry E Heath
Linda Dekker
Paul A LeBlanc
Robin S Simmonds
Shaw R Gargis
P2860
P304
P356
10.1128/AEM.01066-10
P407
P577
2010-08-20T00:00:00Z